vs
Side-by-side financial comparison of Matador Resources Co (MTDR) and West Pharmaceutical Services (WST). Click either name above to swap in a different company.
Matador Resources Co is the larger business by last-quarter revenue ($809.5M vs $805.0M, roughly 1.0× West Pharmaceutical Services). Matador Resources Co runs the higher net margin — 23.8% vs 16.4%, a 7.4% gap on every dollar of revenue. On growth, West Pharmaceutical Services posted the faster year-over-year revenue change (7.5% vs -17.2%). West Pharmaceutical Services produced more free cash flow last quarter ($175.0M vs $8.1M). Over the past eight quarters, West Pharmaceutical Services's revenue compounded faster (7.6% CAGR vs 1.5%).
Matador Resources Co is an independent energy firm engaged in the exploration, development, production and acquisition of oil, natural gas, and natural gas liquids. Its core operations are in major U.S. onshore resource basins, primarily serving North American energy markets.
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.
MTDR vs WST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $809.5M | $805.0M |
| Net Profit | $192.5M | $132.1M |
| Gross Margin | — | 37.8% |
| Operating Margin | 30.0% | 19.5% |
| Net Margin | 23.8% | 16.4% |
| Revenue YoY | -17.2% | 7.5% |
| Net Profit YoY | -10.2% | 1.5% |
| EPS (diluted) | $1.54 | $1.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $809.5M | $805.0M | ||
| Q3 25 | $915.1M | $804.6M | ||
| Q2 25 | $925.7M | $766.5M | ||
| Q1 25 | $1.0B | $698.0M | ||
| Q4 24 | $978.3M | $748.8M | ||
| Q3 24 | $860.1M | $746.9M | ||
| Q2 24 | $855.2M | $702.1M | ||
| Q1 24 | $785.3M | $695.4M |
| Q4 25 | $192.5M | $132.1M | ||
| Q3 25 | $176.4M | $140.0M | ||
| Q2 25 | $150.2M | $131.8M | ||
| Q1 25 | $240.1M | $89.8M | ||
| Q4 24 | $214.5M | $130.1M | ||
| Q3 24 | $248.3M | $136.0M | ||
| Q2 24 | $228.8M | $111.3M | ||
| Q1 24 | $193.7M | $115.3M |
| Q4 25 | — | 37.8% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 35.7% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | — | 32.8% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 30.0% | 19.5% | ||
| Q3 25 | 33.4% | 20.8% | ||
| Q2 25 | 31.2% | 20.1% | ||
| Q1 25 | 38.7% | 15.3% | ||
| Q4 24 | 36.8% | 21.3% | ||
| Q3 24 | 45.6% | 21.6% | ||
| Q2 24 | 42.5% | 18.0% | ||
| Q1 24 | 40.6% | 17.7% |
| Q4 25 | 23.8% | 16.4% | ||
| Q3 25 | 19.3% | 17.4% | ||
| Q2 25 | 16.2% | 17.2% | ||
| Q1 25 | 23.9% | 12.9% | ||
| Q4 24 | 21.9% | 17.4% | ||
| Q3 24 | 28.9% | 18.2% | ||
| Q2 24 | 26.8% | 15.9% | ||
| Q1 24 | 24.7% | 16.6% |
| Q4 25 | $1.54 | $1.82 | ||
| Q3 25 | $1.42 | $1.92 | ||
| Q2 25 | $1.21 | $1.82 | ||
| Q1 25 | $1.92 | $1.23 | ||
| Q4 24 | $1.71 | $1.78 | ||
| Q3 24 | $1.99 | $1.85 | ||
| Q2 24 | $1.83 | $1.51 | ||
| Q1 24 | $1.61 | $1.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.3M | $791.3M |
| Total DebtLower is stronger | $3.4B | $202.8M |
| Stockholders' EquityBook value | $5.7B | $3.2B |
| Total Assets | $11.7B | $4.3B |
| Debt / EquityLower = less leverage | 0.60× | 0.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.3M | $791.3M | ||
| Q3 25 | $20.1M | $628.5M | ||
| Q2 25 | $10.5M | $509.7M | ||
| Q1 25 | $14.5M | $404.2M | ||
| Q4 24 | $23.0M | $484.6M | ||
| Q3 24 | $23.3M | $490.9M | ||
| Q2 24 | $15.2M | $446.2M | ||
| Q1 24 | $23.2M | $601.8M |
| Q4 25 | $3.4B | $202.8M | ||
| Q3 25 | $3.2B | $202.7M | ||
| Q2 25 | $3.3B | $202.6M | ||
| Q1 25 | $3.2B | $202.6M | ||
| Q4 24 | $3.3B | $202.6M | ||
| Q3 24 | — | $202.6M | ||
| Q2 24 | — | $205.8M | ||
| Q1 24 | — | $206.2M |
| Q4 25 | $5.7B | $3.2B | ||
| Q3 25 | $5.5B | $3.1B | ||
| Q2 25 | $5.4B | $2.9B | ||
| Q1 25 | $5.3B | $2.7B | ||
| Q4 24 | $5.1B | $2.7B | ||
| Q3 24 | $4.9B | $2.8B | ||
| Q2 24 | $4.6B | $2.6B | ||
| Q1 24 | $4.4B | $2.7B |
| Q4 25 | $11.7B | $4.3B | ||
| Q3 25 | $11.6B | $4.1B | ||
| Q2 25 | $11.3B | $4.0B | ||
| Q1 25 | $11.1B | $3.6B | ||
| Q4 24 | $10.9B | $3.6B | ||
| Q3 24 | $10.6B | $3.7B | ||
| Q2 24 | $8.5B | $3.5B | ||
| Q1 24 | $8.2B | $3.6B |
| Q4 25 | 0.60× | 0.06× | ||
| Q3 25 | 0.58× | 0.07× | ||
| Q2 25 | 0.61× | 0.07× | ||
| Q1 25 | 0.60× | 0.08× | ||
| Q4 24 | 0.65× | 0.08× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.08× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $474.4M | $251.1M |
| Free Cash FlowOCF − Capex | $8.1M | $175.0M |
| FCF MarginFCF / Revenue | 1.0% | 21.7% |
| Capex IntensityCapex / Revenue | 57.6% | 9.5% |
| Cash ConversionOCF / Net Profit | 2.46× | 1.90× |
| TTM Free Cash FlowTrailing 4 quarters | $269.6M | $468.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $474.4M | $251.1M | ||
| Q3 25 | $721.7M | $197.2M | ||
| Q2 25 | $501.0M | $177.1M | ||
| Q1 25 | $727.9M | $129.4M | ||
| Q4 24 | $575.0M | $190.1M | ||
| Q3 24 | $610.4M | $180.1M | ||
| Q2 24 | $592.9M | $165.0M | ||
| Q1 24 | $468.6M | $118.2M |
| Q4 25 | $8.1M | $175.0M | ||
| Q3 25 | $78.3M | $133.9M | ||
| Q2 25 | $9.6M | $101.9M | ||
| Q1 25 | $173.6M | $58.1M | ||
| Q4 24 | $45.2M | $85.2M | ||
| Q3 24 | $-1.6B | $98.8M | ||
| Q2 24 | $69.0M | $64.8M | ||
| Q1 24 | $-170.0M | $27.6M |
| Q4 25 | 1.0% | 21.7% | ||
| Q3 25 | 8.6% | 16.6% | ||
| Q2 25 | 1.0% | 13.3% | ||
| Q1 25 | 17.3% | 8.3% | ||
| Q4 24 | 4.6% | 11.4% | ||
| Q3 24 | -186.5% | 13.2% | ||
| Q2 24 | 8.1% | 9.2% | ||
| Q1 24 | -21.6% | 4.0% |
| Q4 25 | 57.6% | 9.5% | ||
| Q3 25 | 70.3% | 7.9% | ||
| Q2 25 | 53.1% | 9.8% | ||
| Q1 25 | 55.1% | 10.2% | ||
| Q4 24 | 54.2% | 14.0% | ||
| Q3 24 | 257.4% | 10.9% | ||
| Q2 24 | 61.3% | 14.3% | ||
| Q1 24 | 81.3% | 13.0% |
| Q4 25 | 2.46× | 1.90× | ||
| Q3 25 | 4.09× | 1.41× | ||
| Q2 25 | 3.34× | 1.34× | ||
| Q1 25 | 3.03× | 1.44× | ||
| Q4 24 | 2.68× | 1.46× | ||
| Q3 24 | 2.46× | 1.32× | ||
| Q2 24 | 2.59× | 1.48× | ||
| Q1 24 | 2.42× | 1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MTDR
| Oil And Gas | $702.8M | 87% |
| Natural Gas Sales | $61.3M | 8% |
| Natural Gas Midstream | $45.4M | 6% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
